Join
Live feed
·
INSIDERFilingvia Quantisnow
ProMIS Neurosciences Inc. logo

Chief Development Officer Kaplan Johanne bought $30,324 worth of shares (2,280 units at $13.30), increasing direct ownership by 58% to 6,221 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PMN· ProMIS Neurosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMN (ProMIS Neurosciences Inc.) and more on Quantisnow.